ruconest
pharming group n.v. - rekombinant human c1-inhibitor - angioødemer, arvelige - drugs used in hereditary angioedema, other hematological agents - ruconest er indiceret til behandling af akut angioødemangreb hos voksne med arveligt angioødem (hae) på grund af c1-esterase-hæmmere mangel.
rapilysin
actavis group ptc ehf - reteplase - myokardieinfarkt - antitrombotiske midler - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - mave neoplasmer - antineoplastiske midler - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
alatopran 5 mg/ml+50 mikrog/ml øjendråber, opløsning
actavis group ptc ehf. - latanoprost, timololmaleat - øjendråber, opløsning - 5 mg/ml+50 mikrog/ml
alopam 10 mg tabletter
actavis group hf. - oxazepam - tabletter - 10 mg
alopam 15 mg tabletter
actavis group hf. - oxazepam - tabletter - 15 mg
amlodipin "actavis" 10 mg tabletter
actavis group ptc ehf. - amlodipinmesilatmonohydrat - tabletter - 10 mg
arzolamid 20 mg/ml øjendråber, opløsning
actavis group ptc ehf. - dorzolamidhydrochlorid - øjendråber, opløsning - 20 mg/ml
arzotilol 20+5 mg/ml øjendråber, opløsning
actavis group ptc ehf. - dorzolamidhydrochlorid, timololmaleat - øjendråber, opløsning - 20+5 mg/ml
azathioprin "actavis" 50 mg filmovertrukne tabletter
actavis group ptc ehf. - azathioprin - filmovertrukne tabletter - 50 mg